|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/01/17 Mimedx Group, Inc. 10-K 12/31/16 96:9.2M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 885K
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 78K
3: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 91K
4: EX-21.1 Subsidiaries List HTML 25K
5: EX-23.1 Consent of Experts or Counsel HTML 27K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 28K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 28K
16: R1 Document and Entity Information HTML 53K
17: R2 Consolidated Balance Sheets HTML 115K
18: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K
19: R4 Consolidated Statements of Operations HTML 73K
20: R5 Consolidated Statements of Stockholders' Equity HTML 107K
21: R6 Consolidated Statements of Cash Flows HTML 113K
22: R7 Nature of Business HTML 30K
23: R8 Significant Accounting Policies HTML 72K
24: R9 Liquidity and Capital Resources HTML 31K
25: R10 Acquisition of Stability Inc. HTML 164K
26: R11 Cash Equivalents and Short Term Investments HTML 28K
27: R12 Inventories HTML 39K
28: R13 Property and Equipment HTML 44K
29: R14 Intangible Assets and Royalty Agreement HTML 70K
30: R15 Long-Term Debt HTML 32K
31: R16 Net Income Per Share HTML 57K
32: R17 Equity HTML 144K
33: R18 Income Taxes HTML 97K
34: R19 Supplemental Disclosure of Cash Flow and Non-Cash HTML 46K
Investing and Financing Activities
35: R20 401k Plan HTML 31K
36: R21 Related Party Transactions HTML 31K
37: R22 Commitments and Contingencies HTML 66K
38: R23 Quarterly Financial Data (Unaudited) HTML 78K
39: R24 Product Revenue Data HTML 45K
40: R25 Subsequent Events HTML 28K
41: R26 Schedule II - Valuation and Qualifying Accounts HTML 73K
42: R27 Significant Accounting Policies (Policies) HTML 137K
43: R28 Acquisition of Stability Inc. (Tables) HTML 154K
44: R29 Inventories (Tables) HTML 40K
45: R30 Property and Equipment (Tables) HTML 41K
46: R31 Intangible Assets and Royalty Agreement (Tables) HTML 70K
47: R32 Net Income Per Share (Tables) HTML 68K
48: R33 Equity (Tables) HTML 142K
49: R34 Income Taxes (Tables) HTML 93K
50: R35 Supplemental Disclosure of Cash Flow and Non-Cash HTML 44K
Investing and Financing Activities (Tables)
51: R36 Commitments and Contingencies (Tables) HTML 34K
52: R37 Quarterly Financial Data (Unaudited) (Tables) HTML 77K
53: R38 Product Revenue Data (Tables) HTML 39K
54: R39 Nature of Business (Details) HTML 27K
55: R40 Significant Accounting Policies (Details) HTML 53K
56: R41 Liquidity and Capital Resources (Details) HTML 40K
57: R42 Acquisition of Stability Inc. - Narrative HTML 74K
(Details)
58: R43 Acquisition of Stability Inc. - Fair Value of HTML 40K
Stock Consideration (Details)
59: R44 Acquisition of Stability Inc. - Preliminarily HTML 121K
Allocation of Purchase Price (Details)
60: R45 Acquisition of Stability Inc. - Intangible Assets HTML 36K
Acquired as Part of Acquisition (Details)
61: R46 Acquisition of Stability Inc. - Goodwill HTML 34K
Reconciliation (Details)
62: R47 Acquisition of Stability Inc. - Measurement Period HTML 117K
Adjustments (Details)
63: R48 Acquisition of Stability Inc. - Pro Forma HTML 32K
Information (Details)
64: R49 Cash Equivalents and Short Term Investments HTML 32K
(Details)
65: R50 Inventories (Details) HTML 40K
66: R51 Property and Equipment (Details) HTML 54K
67: R52 Intangible Assets and Royalty Agreement - HTML 98K
Intangible Asssets Activity Summary (Details)
68: R53 Intangible Assets and Royalty Agreement - HTML 29K
Narrative (Details)
69: R54 Intangible Assets and Royalty Agreement - Expected HTML 42K
Future Amortization of Intangible Assets (Details)
70: R55 Long-Term Debt (Details) HTML 47K
71: R56 Net Income Per Share - Computation of Basic and HTML 50K
Dilutive Net Loss per Share (Details)
72: R57 Net Income Per Share - Summary of Antidilutive HTML 38K
Securities (Details)
73: R58 Equity - Narrative (Details) HTML 82K
74: R59 Equity - Activity of Stock Options (Details) HTML 80K
75: R60 Equity - Exercise Price Ranges (Details) HTML 77K
76: R61 Equity - Summary of Unvested Stock Options HTML 46K
(Details)
77: R62 Equity - Assumptions (Details) HTML 45K
78: R63 Equity - Summary of Restricted Stock Awards HTML 51K
(Details)
79: R64 Equity - Recognized Stock-Based Compensation HTML 36K
(Details)
80: R65 Income Taxes - Deferred Tax Assets and Liabilities HTML 52K
(Details)
81: R66 Income Taxes - Reconciliation of the Federal HTML 60K
Statutory Income Tax (Details)
82: R67 Income Taxes - Schedule of current and deferred HTML 51K
income tax expense (Benefit) (Details)
83: R68 Income Taxes - Narrative (Details) HTML 51K
84: R69 Income Taxes - Reconciliation of unrecognized tax HTML 31K
benefits (Details)
85: R70 Supplemental Disclosure of Cash Flow and Non-Cash HTML 48K
Investing and Financing Activities (Details)
86: R71 401k Plan (Details) HTML 38K
87: R72 Related Party Transactions (Details) HTML 34K
88: R73 Commitments and Contingencies - Narrative HTML 56K
(Details)
89: R74 Commitments and Contingencies - Estimated Annual HTML 38K
Lease, Royalty, and Employment Agreement Expenses
(Details)
90: R75 Quarterly Financial Data (Unaudited) (Details) HTML 46K
91: R76 Product Revenue Data (Details) HTML 37K
92: R77 Subsequent Events (Details) HTML 33K
93: R78 Schedule II - Valuation and Qualifying Accounts HTML 42K
(Details)
95: XML IDEA XML File -- Filing Summary XML 163K
94: EXCEL IDEA Workbook of Financial Reports XLSX 106K
10: EX-101.INS XBRL Instance -- mdxg-20161231 XML 2.32M
12: EX-101.CAL XBRL Calculations -- mdxg-20161231_cal XML 269K
13: EX-101.DEF XBRL Definitions -- mdxg-20161231_def XML 662K
14: EX-101.LAB XBRL Labels -- mdxg-20161231_lab XML 1.86M
15: EX-101.PRE XBRL Presentations -- mdxg-20161231_pre XML 1.11M
11: EX-101.SCH XBRL Schema -- mdxg-20161231 XSD 167K
96: ZIP XBRL Zipped Folder -- 0001376339-17-000042-xbrl Zip 257K
| Exhibit |
1. | I have reviewed this annual report on Form 10-K of MiMedx Group, Inc.; |
2. | Based
on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this annual report is being prepared, |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, |
(c) | evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation, and |
(d) | disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent
function): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
/s/: Parker H. Petit | ||
Parker H. Petit | ||
Chief
Executive Officer | ||
(principal executive officer) | ||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/1/17 | |||
| For Period end: | 12/31/16 | 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/17/20 Mimedx Group, Inc. S-8 12/17/20 5:422K Donnelley … Solutions/FA 11/04/20 Mimedx Group, Inc. 10-Q 9/30/20 79:7.4M 11/02/20 Mimedx Group, Inc. 8-A12B 1:37K 8/04/20 Mimedx Group, Inc. 10-Q 6/30/20 71:5.9M 3/20/17 SEC UPLOAD¶ 9/28/17 1:173K Mimedx Group, Inc. |